Project Grant R21AR084034
- This federal Project Grant award of $286,791, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop pediatric-specific blood transcriptional modules (pBTMs) that capture the broad range of heterogeneous physiological states in children across diverse geographical settings. The project will construct these modules using transcriptome data from over 13,000 samples across 76 studies...
- This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), provides $4,638,918 in funding to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to develop a precision health model for identifying and monitoring pediatric chronic primary pain. The key objectives are to: 1) Leverage the PEDSnet national pediatric learning health system to develop a computable...
- This federal Project Grant award, funded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113), is supporting research to characterize the early life chemical exposome and its impact on structural and functional brain development in young children. The University of North Carolina at Chapel Hill (UNC-CH) is the primary awardee, receiving $249,000 to leverage their ongoing Baby Connectome Project which maps brain growth and...
- This Project Grant award of $673,538, provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund a multi-method assessment of how health policies affect the health outcomes and healthcare of reproductive-age females with systemic autoimmune and rheumatic diseases (SARDs). The University of Pittsburgh will lead this study, which includes qualitative...
- This Project Grant award of $170,490 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to develop and validate computable phenotypes for pediatric atopic dermatitis and compare the effectiveness and safety of dupilumab versus methotrexate for treating this condition. The funding will enable The Johns Hopkins University to utilize electronic health...
- This $135,000 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support a research project titled "Air Pollution Sensitivity in Pediatric Asthma". The primary objectives are to investigate how clinical, genetic, and social factors interact with short-term ambient air pollution (AAP) variations to influence asthma exacerbation incidence, as well as examine how these variables shape...
- This Cooperative Agreement award of $830,887 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports the ARISEN (Autoimmunity, Rasmussen's, Inflammation & Status Epilepticus Research Network) project. ARISEN is a multi-center registry and research network focused on rare and poorly understood neuroinflammatory diseases in children and adults, such as autoimmune encephalitis,...
- The National Institute of Environmental Health Sciences (NIEHS) awarded a $558,380 Project Grant under the Environmental Health federal grant program (CFDA 93.113) to the Icahn School of Medicine at Mount Sinai (ISMMS) to develop the GEOSPACE Geospatial Knowledgebase for Exposomics. This four-year project, starting February 1, 2025, aims to create an integrated biomedical knowledgebase and geospatial data science ecosystem to facilitate robust exposomic studies. The key products include: A...
- This Project Grant award of $263,026 from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) supports the development, piloting, and refinement of an online, self-administered intervention for stress reduction and cardiovascular health behavior promotion in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM). The overall objective is to engage this patient population as partners in adapting a...
- This Project Grant award, funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to study the role of early life social determinants and sex-specific pubertal pathways in the development of adolescent chronic pain. The project will follow approximately 415 mother-child dyads across four U.S. sites, with the goal of identifying longitudinal associations between early life...
DEVELOPMENT OF FOUNDATIONAL COLLABORATIONS AND CAPABILITIES TO ADVANCE EXPOSOME RESEARCH IN CHILDHOOD-ONSET RHEUMATIC DISEASES AND OTHER PEDIATRIC AUTOIMMUNE CONDITIONS - PROJECT SUMMARY THE PRIMARY VISION OF THIS PROJECT IS THE ESTABLISHMENT OF INVESTIGATOR AND NETWORK COLLABORATIONS THAT WILL ADVANCE STUDY OF THE ROLE OF THE EXPOSOME IN CHILDHOOD-ONSET RHEUMATIC DISEASES AND OTHER AUTOIMMUNE CONDITIONS, WITH AN OVERARCHING GOAL OF CREATING NEW RESEARCH RESOURCES AND FORMING NEW TEAMS OF PEDIATRIC INVESTIGATORS FROM EXISTING NETWORKS THAT CAN CONTRIBUTE TO THE NASCENT "EXPOSOME IN AUTOIMMUNE DISEASE COLLABORATING TEAMS" (EXACT) NETWORK. THE RECENT NATIONAL ACADEMIES OF SCIENCE, ENGINEERING AND MEDICINE REPORT "ENHANCING NIH RESEARCH ON AUTOIMMUNE DISEASE" (2022), WHICH IDENTIFIED "GAP AREAS" IN CONTEMPORARY RESEARCH EFFORTS OF AUTOIMMUNE DISEASES THAT THE EXACT-PLAN NOTICE OF SPECIAL INTEREST ADDRESSES, SPECIFICALLY ENDORSES A LIFE-COURSE APPROACH THAT INCLUDES A FOCUS ON CHILDREN AND ADOLESCENTS. WE SEEK TO ADDRESS THIS FOCUS VIA COLLABORATION BETWEEN TWO EXISTING PEDIATRIC NETWORKS WITH EXTENSIVE EXISTING PHENOTYPE AND BIOBANK RESOURCES: THE INVESTIGATOR-SPONSORED CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE (CARRA), WHICH SPONSORS THE CARRA REGISTRY, AND THE NIH/NCATS FUNDED GENOMIC INFORMATION COMMONS (GIC). THE CARRA REGISTRY HAS ENROLLED >13,000 SUBJECTS FROM >70 SITES, WITH NEARLY 1,900 BIOBANKED SPECIMENS, AND IS THE LARGEST LONGITUDINAL CHRONIC DISEASE REGISTRY FOR CHILDHOOD-ONSET RHEUMATIC DISEASES IN NORTH AMERICA, WITH CLINICAL DATA COLLECTION AND BIOBANKING IN 4 DISEASE CATEGORIES: JUVENILE IDIOPATHIC ARTHRITIS, SYSTEMIC LUPUS ERYTHEMATOSUS/MIXED CONNECTIVE TISSUE DISEASE/SJOGREN'S SYNDROME, JUVENILE DERMATOMYOSITIS, AND LOCALIZED AND SYSTEMIC SCLERODERMA. THE GIC NETWORK IS A COOPERATIVE, PHENOTYPE-GENOTYPE BIOBANKING EFFORT WITH 8 PARTICIPATING PEDIATRIC ACADEMIC MEDICAL CENTERS ACROSS THE US, WITH BROAD REPRESENTATION OF SUBJECTS WITH DIFFERING CONDITIONS (13.7 MILLION SUBJECTS, ~30,000 WITH GENOME- LINKED PHENOTYPIC DATA, 160,000 BIOSPECIMENS COLLECTED) AND PROVIDES SEARCH ACROSS SITES TO IDENTIFY COHORTS OF INDIVIDUALS WITH AND WITHOUT RHEUMATIC OR AUTOIMMUNE DISEASES, WITH INFRASTRUCTURE ALSO SUPPORTING SUBJECT RECRUITMENT AND BIOBANKING FOR FUTURE STUDIES. OUR AIMS FOR THIS PROJECT ARE TWO-FOLD: (1) ESTABLISH A COLLABORATIVE FRAMEWORK BETWEEN INVESTIGATORS OF THE CARRA AND GIC NETWORKS FOR AUGMENTING CURRENT RESEARCH ACTIVITIES WITH EXPOSOME DATA AND BIOBANK SPECIMENS; AND (2) PILOT THE LINKAGE OF PUBLICLY AVAILABLE EXPOSOME DATA SETS, INCLUDING AIR AND WATER QUALITY DATABASES, TO EXISTING DATA SETS THAT THE CARRA REGISTRY AND GIC MAINTAIN. WE WILL DEVELOP AND ADAPT POLICIES, PROTOCOLS, INFORMED CONSENTS, CASE REPORT FORMS, AND PATIENT SURVEYS THAT ARE SPECIFICALLY TARGETED TO INCORPORATING EXPOSOME DATA FOR CHILDHOOD-ONSET RHEUMATIC DISEASES AND OTHER AUTOIMMUNE CONDITIONS. OUR MULTI-DISCIPLINARY PROJECT TEAM INCLUDES RESEARCHERS IN PEDIATRIC RHEUMATOLOGY AND THE EXPOSOME, TECHNOLOGY EXPERTS, AND PATIENT REPRESENTATIVES. COMPLETION OF THE AIMS OF THIS PROJECT WILL ENABLE NEW TEAM-BASED COLLABORATIONS TO CONDUCT FUTURE HIGH-QUALITY, BEST-PRACTICES EXPOSOME RESEARCH FOR MANY PEDIATRIC AUTOIMMUNE DISEASES AS PART OF THE FUTURE EXACT NETWORK.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/15/25 | ||
| Not listed | $0 | 9/15/25 | ||
| Not listed | $222.5k | 8/19/25 | ||
| Not listed | $486.8k | 9/19/23 |